Mechanisms of Mitochondrial Dysfunction in Alzheimer’s Disease

Mitochondria are the primary source for energy generation in the cell, which manifests itself in the form of the adenosine triphosphate (ATP). Nicotinamide dinucleotide (NADH) molecules are the first to enter the so-called electron transport chain or ETC of the mitochondria. The ETC represents a cha...

Full description

Saved in:
Bibliographic Details
Published in:Molecular neurobiology 2016-11, Vol.53 (9), p.6078-6090
Main Authors: Cadonic, Chris, Sabbir, Mohammad Golam, Albensi, Benedict C.
Format: Article
Language:English
Subjects:
Adenosine triphosphatase
Alzheimer Disease - metabolism
Alzheimer Disease - pathology
Alzheimer Disease - physiopathology
Alzheimer's disease
Animals
Biomedical and Life Sciences
Biomedicine
Cell Biology
Disease Progression
Electron transfer
Electron Transport
Energy Metabolism
Humans
Mitochondria
Mitochondria - metabolism
Mitochondria - pathology
Neurobiology
Neurology
Neurosciences
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Mitochondria are the primary source for energy generation in the cell, which manifests itself in the form of the adenosine triphosphate (ATP). Nicotinamide dinucleotide (NADH) molecules are the first to enter the so-called electron transport chain or ETC of the mitochondria. The ETC represents a chain of reducing agents organized into four major protein-metal complexes (I-IV) that utilize the flow of electrons to drive the production of ATP. An additional integral protein that is related to oxidative phosphorylation is ATP synthase, referred to as complex V. Complex V carries out ATP synthesis as a result of the electron flow through the ETC. The coupling of electron flow from NADH to molecular oxygen to the production of ATP represents a process known as oxidative phosphorylation. In this review, we describe mainly the bioenergetic properties of mitochondria, such as those found in the ETC that may be altered in Alzheimer’s disease (AD). Increasing evidence points to several mitochondrial functions that are affected in AD. Furthermore, it is becoming apparent that mitochondria are a potential target for treatment in early-stage AD. With growing interest in the mitochondria as a target for AD, it has been hypothesized that deficit in this organelle may be at the heart of the progression of AD itself. The role of mitochondria in AD may be significant and is emerging as a main area of AD research.
ISSN:0893-7648
1559-1182
DOI:10.1007/s12035-015-9515-5